United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ] . glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets usp are contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product's ingredients [see warnings and precautions (5.2) ] . sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride tablets. do not use glimepiride tablets in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (see dosage and administration section ).   glimepiride tablets are contraindicated in patients with 1. known hypersensitivity to the drug. 2. diabetic ketoacidosis, with or without coma. this condition should be treated with insulin. 

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - glimepiride - tablet - 4 milligram(s) - sulfonamides, urea derivatives; glimepiride

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - glimepiride - tablet - 4 milligram(s) - sulfonamides, urea derivatives; glimepiride

Canada - English - Health Canada

pharmascience inc - glimepiride - tablet - 1mg - glimepiride 1mg - sulfonylureas

Canada - English - Health Canada

pharmascience inc - glimepiride - tablet - 2mg - glimepiride 2mg - sulfonylureas

Canada - English - Health Canada

apotex inc - glimepiride - tablet - 1mg - glimepiride 1mg - sulfonylureas

Canada - English - Health Canada

apotex inc - glimepiride - tablet - 2mg - glimepiride 2mg - sulfonylureas

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to:  - glimepiride or any of the product’s ingredients [see warnings and precautions (5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives.   reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions (5.2) and adverse reaction

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - glimepiride -